Charles Warren Bennington, CEO, President and Secretary at TransBiotec, Inc. (IMLE), bought 14,000,000 shares at $0.04 ($560K) on 2019-08-28, disclosed to the SEC on 2019-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SOBR | SELL | 2021-05-18 | $3K | — | Filing → |
| SOBR | SELL | 2021-04-28 | $3K | — | Filing → |
| SOBR | BUY | 2020-10-01 | $66.0M | — | Filing → |